title: Dose Response of MTLn3 Cells to Serial Dilutions of Arsenic Trioxide and Ionizing Radiation.
abstract: MTLn3 cells derived from mouse mammary epithelium are known to be highly malignant and are resistant to both radio- and chemo-therapy. We exposed MTLn3 cells to various doses of inorganic Arsenic trioxide (As2O3) in combination with ionizing radiation. Cells were treated with a series of As2O3 concentrations ranging from 20 μM to 1.22 nM for 8 hour, 24 hour and 48 hour periods. Post-treated cell proliferation was quantified by measuring mitochondrial activity and DNA analysis. Cells exposed to radiation and As2O3 at concentration greater than 1.25 μM showed apoptosis and radiations alone treated cells were statistically not different from the control. Hormesis was observed for As2O3 concentrations in the range of 0.078 μM to 0.625 μM while the combined chemo and radiation treatments of the cells did not affect the hormetic effect. We have demonstrated that As2O3 (in the presence and absence of ionizing radiation) in specific low concentrations induced apoptosis in the otherwise chemoresistant cancer cells. This low concentration-mediated cell death is immediately followed by a surge in cell survival. Low dosing dosimetry is highly desirable in metronomic therapy however, it has a narrow window since necrosis, hormesis, apoptosis and other dose-dependent biological processes take place in this region. Further quantifiable dosimetry is highly desired for routine clinical practice.
authors.affiliation: Biomedical Engineering, Tufts University and College of Nanoscale Science and Engineering, University at Albany.
authors.forename: Waseem Khan
authors.initials: WK
authors.lastname: Raja
authors.forename: Jahangir
authors.initials: J
authors.lastname: Satti
authors.forename: Gang
authors.initials: G
authors.lastname: Liu
authors.forename: James
authors.initials: J
authors.lastname: Castracane
keywords: Apoptosis; Arsenic trioxide; Cancer cells; Hormesis; Ionizing radiation
references.citation: Environ Sci Technol. 2011 Feb 15;45(4):1623-9
references.pmid: 21194196
references.citation: Biogerontology. 2011 Jun;12(3):253-63
references.pmid: 21234801
references.citation: Adv Exp Med Biol. 2007;608:1-22
references.pmid: 17993229
references.citation: Am J Clin Oncol. 2008 Aug;31(4):393-8
references.pmid: 18846001
references.citation: Acta Haematol. 2005;114(4):248-54
references.pmid: 16269865
references.citation: Cancer Treat Rev. 2011 Jun;37(4):300-11
references.pmid: 21126826
references.citation: Biomaterials. 2011 Jun;32(17):4130-9
references.pmid: 21411140
references.citation: Sci Total Environ. 2008 Oct 1;404(1):77-87
references.pmid: 18640701
references.citation: J Biol Chem. 2008 May 23;283(21):14497-505
references.pmid: 18362141
references.citation: Curr Med Chem. 2008;15(22):2293-304
references.pmid: 18781951
references.citation: Cancer Chemother Pharmacol. 2011 Nov;68(5):1119-24
references.pmid: 21373895
references.citation: J BUON. 2010 Oct-Dec;15(4):758-62
references.pmid: 21229642
references.citation: Neoplasia. 2011 Jan;13(1):40-8
references.pmid: 21245939
references.citation: Exp Clin Cardiol. 2010 Winter;15(4):e134-8
references.pmid: 21264071
references.citation: J Urol. 2007 Jun;177(6):2136-40; discussion 2140
references.pmid: 17509300
references.citation: Cancer Res. 2004 Nov 1;64(21):7664-7
references.pmid: 15520165
references.citation: Drugs Aging. 2010 Sep 1;27(9):689-96
references.pmid: 20809660
references.citation: J Proteomics. 2010 May 7;73(7):1342-54
references.pmid: 20219715
references.citation: Dose Response. 2009 Mar 24;7(3):208-20
references.pmid: 19809540
references.citation: Environ Res. 2010 Jul;110(5):413-6
references.pmid: 19800058
references.citation: Cancer Res. 2006 Jan 1;66(1):192-7
references.pmid: 16397232
references.citation: Integr Biol (Camb). 2010 Nov;2(11-12):696-706
references.pmid: 20938544
references.citation: Ann Oncol. 2011 Sep;22(9):1939-1947
references.pmid: 21289366
references.citation: Autophagy. 2010 Apr;6(3):353-65
references.pmid: 20200477
references.citation: Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):197-203
references.pmid: 15337556
references.citation: Recent Results Cancer Res. 2010;180:165-83
references.pmid: 20033383
references.citation: Mol Cancer Ther. 2008 Jul;7(7):2060-9
references.pmid: 18645016
references.citation: Int J Biol Markers. 2010 Oct-Dec;25(4):243-7
references.pmid: 21161947
references.citation: J Biol Chem. 2009 Jul 10;284(28):18583-7
references.pmid: 19363033
references.citation: J Clin Oncol. 2010 Mar 1;28(7):1232-9
references.pmid: 20124178
references.citation: Crit Rev Oncol Hematol. 2012 Jan;81(1):29-37
references.pmid: 21333547